BRAND NAME:
Romilast

GENERIC NAME:
Roflumilast

THERAPEUTIC SEGMENT:
Phosphodiesterase Inhibitor

INDICATIONS:
COPD

BRIEF DESCRIPTION:
Roflumilast is a 1st and only approved PDE-4 inhibitor molecule in COPD treatment. It is recommended by GOLD Guidelines as a Once Daily unique and selective anti-inflammatory molecule to reduce exacerbation rate and improve lung function in COPD Patients.

DOSAGE FORM:
500mcg Tablets

PACK SIZE:
10's